Lead Programs Manager, Peptides

What You'll Do

• Own the strategy. Define the multi-quarter roadmap for Peptides, including the metrics that matter, the bets we're making, and the sequencing that gets us there. Defend it to the executive team and adjust it as the market and our data demand.
• Close the deliverable-to-goal gap. Continuously verify that what's being built matches the strategic plan — and when it doesn't, escalate, re-scope, or re-align. The gap between roadmap and reality is your accountability.
• Set the operating goals. Translate company-level OKRs into program-level targets — clinical quality, patient outcomes, client retention, unit economics, growth velocity. Pick the right metrics; defend them against vanity alternatives.
• Make build/buy/partner calls. Decide where we build, where we integrate, and where we partner. Bring data, scenarios, and a recommendation.
• Lead without authority. Align Clinical, Product, Engineering, Pharmacy, RCM, Implementation, Marketing, and Client Success behind a single program direction.
• Own the program narrative for senior leadership. Run the program review and translate complex operational and clinical dynamics into clear decisions and tradeoffs.
• Guide Program Managers. Guide and prioritize the work of Program Managers supporting the program.
• Own client outcomes for the program. Be the executive escalation point for major client questions and program-level commitments.
• Translate client and market signal. Synthesize what we hear from clients, what the regulatory environment is doing, and what competitors are shipping into roadmap decisions.
• Drive program-level commercial outcomes. Partner with Commercial and Client Success to make sure the program is sellable, expandable, and retainable.

Who You Are

• 7–10+ years of experience owning programs, products, or operating units in healthcare, digital health, health tech, or closely adjacent fields. At least 3 years setting strategy and owning a roadmap end-to-end.
• Direct experience of peptide-based therapies or closely adjacent care models, including understanding of the regulatory landscape around compounded peptides, FDA bulks list dynamics, peptide categories (GHK-Cu, BPC-157, semaglutide, tirzepatide, sermorelin, etc.), and the clinical evidence base.
• Track record of strategy ownership, not just execution.
• Demonstrated cross-functional leadership.
• Strong commercial and analytical instincts.
• Exceptional written communication.
• Built structure in fast-moving environments. Worked at the velocity hypergrowth requires without letting documentation, protocols, and clinical/operational rigor slip.
• Strong compliance instinct. Operating with rigorous attention to clinical, regulatory, and data-security standards.